Literature DB >> 29709545

DPP9 enzymatic activity in hematopoietic cells is dispensable for mouse hematopoiesis.

Munkyung Kim1, Lilly von Muenchow2, Thomas Le Meur1, Benjamin Kueng1, Berangere Gapp1, Delphine Weber1, William Dietrich3, Jiri Kovarik1, Antonius G Rolink2, Iwona Ksiazek4.   

Abstract

Dipeptidyl peptidase 9 (DPP9) is a ubiquitously expressed intracellular prolyl peptidase implicated in immunoregulation. However, its physiological relevance in the immune system remains largely unknown. We investigated the role of DPP9 enzyme in immune system by characterizing DPP9 knock-in mice expressing a catalytically inactive S729A mutant of DPP9 enzyme (DPP9ki/ki mice). DPP9ki/ki mice show reduced number of lymphoid and myeloid cells in fetal liver and postnatal blood but their hematopoietic cells are fully functional and able to reconstitute lymphoid and myeloid lineages even in competitive mixed chimeras. These studies demonstrate that inactivation of DPP9 enzymatic activity does not lead to any perturbations in mouse hematopoiesis.
Copyright © 2018 European Federation of Immunological Societies. All rights reserved.

Entities:  

Keywords:  Competitive reconstitution assay; DPP9; DPP9 knock-in enzyme inactive mice; Dipeptidyl peptidase; Hematopoiesis; Hematopoietic stem cells

Mesh:

Substances:

Year:  2018        PMID: 29709545     DOI: 10.1016/j.imlet.2018.04.008

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  2 in total

1.  Immune regeneration in irradiated mice is not impaired by the absence of DPP9 enzymatic activity.

Authors:  Margaret G Gall; Hui Emma Zhang; Quintin Lee; Christopher J Jolly; Geoffrey W McCaughan; Adam Cook; Ben Roediger; Mark D Gorrell
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

Review 2.  New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors.

Authors:  Chenkai Cui; Xuefei Tian; Linting Wei; Yinhong Wang; Kexin Wang; Rongguo Fu
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.